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Treatment of recurrent syndrome of inappropriate secretion of
antidiuretic hormone (SIADH) with lithium. Robert S. Baker, R.
Morrison Hurley, William Feldman. Department of Pediatrics,
McMaster University, Hamilton, Ontario. The usual treatment for
recurrent syndrome of inappropriate secretion of antidiuretic hor-
mone has been fluid restriction. Recently White and Fetner de-
scribed an adult with SIADH successfully managed with lithium
carbonate. Described here is a child with recurrent SIADH who
was diagnosed as having an acute hyponatremic episode and who
then relapsed twice in a two-month period while chronic fluid
restriction was attempted. He has now been maintained on 300
mg/day of lithium carbonate and is asymptomatic with normal
serum sodium and urine osmolalities. Lithium appears to be effec-
tive in the management of recurrent SIADH and may allow con-
trol in a patient who cannot comply with long term fluid restric-
Effect of metabolic alkalosis upon respiratory function in patients
with chronic obstructive lung disease (COLD). R. A. Bear, M.
Hammeke, M. Ho, E. A. Phillipson, M. B. Goldstein, and M. L.
Halperin. Univ. of Toronto, Toronto, Canada. Six patients with
COLD, steady state chronic respiratory acidosis, and in addition,
metabolic alkalosis (M. Alk) were studied to determine the effect
of M. Alk upon respiratory function. M. Alk was diagnosed when
the blood pH exceeded the 95% confidence limits for simple
chronic respiratory acidosis. Optimum clinical condition was
achieved with standard conservative therapy for COLD. Serum
bicarbonate values were then lowered by ammonium chloride or
acetazolamide until they fell within the 95% confidence band for
simple chronic respiratory acidosis. At least two pre- and two post-
treatment blood determinations were obtained on each patient.
Before After
therapy therapy
[HF], nEq/liter 36.8 + 0.5 43.3 1.3 (P < 0.05)
[HCO3-], mEq/liter 38.0 + 2.0 28.3 1.2 (P < 0.01)
P0,mmHg 55.5 1.8 49.1 + 1.6 (P< 0.05)
P02, mm Hg 58.6 + 6.0 78.5 7.4 (P < 0.01)
Correction of M. Alk led to increases in oxygen pressure (Pco)
greater than would have been predicted solely on the basis of the
changes in carbon dioxide pressure (P0). Return of [H] to levels
within the 95% confidence limits for chronic respiratory acidosis
may also improve ventilation by stimulating hydrogen-sensitive
respiratory centers.
Summary. In patients with respiratory acidosis and superimposed
M. Alk, correction of the latter disorder results in significant
improvement in respiratory function. There was also a marked
subjective improvement noted by these patients.
Endogenous Staphylococcus aureus infection in renal transplant
recipients. W. A. Black, Marie Grabec, C. R. Stiller. University
Hospital, London, Ontario, Canada. A prospective study of 62 renal
transplants in 54 patients was made to determine the incidence of
Staphylococcus aureus infections and to establish whether such
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infections were endogenous or exogenous. On admission to the
hospital, specimens were collected from the nose, throat, hands,
hair, ears, groin, urethra, axillae, and rectum. Specimens were
examined for bacteria and fungi. All isolates of Staphylococcus
aureus were phage-typed. These phage-types were compared to
those of Staphylococcus aureus strains isolated from postoperative
infections. Staphylococcus aureus was a common preoperative
commensal and postoperative pathogen. The incidence of post-
operative infection was associated with preoperative carriage.
Thus, postoperative infections occurred in 26 of the 39 cases where
there was preoperative carriage but in only 4 of the 21 cases where
there was no preoperative carriage. This difference is significant. Of
the 31 infectious episodes in the 26 patients mentioned above, 21
episodes were clearly endogenous, 6 were clearly exogenous, and 4
were inconclusive. All three cases of Staphylococcus aureus septi-
cemia were endogenous in origin. Nasal carriage seemed most
important. In this series, infections with systemic mycoses did not
pose a serious problem. These findings would appear to justify the
evaluation of routine antistaphylococcal prophylaxis in this group
of patients.
Spurious hypocalcemia in hemodialysis patients. E. C. Cameron,
W. Godolphin, J. Frohlich, and J. D. E. Price. Renal Unit and
Division of Clinical Chemistry, Vancouver General Hospital, Van-
couver, B.C. Frequent occurrence of spurious hypocalcemia was
observed in 7 of 18 hemodialysis patients after transfer from
arteriovenous shunt (AVS) to fistula (AVF). Blood samples were
taken from AVS patients before systemic heparinization and from
AVF patients after heparin. Fifty-four paired pre-heparin (NH)
and post-heparin (H) predialysis blood samples were obtained
from three AVF patients to determine the cause of spurious hypo-
calcemia. Calcium phosphate, lipid, and lipoprotein levels were
determined. Calcium was decreased in H vs. NH in 20 paired
samples. In these pairs, NH blood contained chylomicrons; H
blood had decreased chylomicron and increased free fatty acid
levels; triglyceride levels were similar in NH and H blood; and H
blood contained a soap-like precipitate composed of calcium and
free fatty acids. These data indicate that release of free fatty acids
and subsequent formation of insoluble calcium soaps occur in
blood samples obtained after systemic heparinization. Heparin
stimulated release of lipoprotein lipase in vivo, and continued
action in vitro in the presence of chylomicrons may be responsible.
Therefore, spurious hypocalcemia may occur in postprandial
blood samples obtained after systemic heparinization.
Effect of extracellular potassium concentration on the proximal
renal tubule perfused in vitro. J. Cardinal. University of Montreal,
Department of Medicine, Maisonneuve-Rosemont Hospital, Mon-
treal, Canada. The presence of potassium (K) is known to be
essential for normal cellular and transepithelial function. The pur-
pose of our study was to evaluate the effect of several different K
concentrations on fluid absorption (Jv) and potential difference
(PD) in rabbit superficial proximal convoluted tubules perfused in
vitro. An artificial Ringer solution was used as the perfusate and
bathing solutions. In addition, the bath contained 6 g/lOO ml of
bovine albumin. In control studies with 5 mEq/liter of K in the
perfusate and bath, mean PD was —2.80 + 0.14mv and mean Jv
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was 0.87 + 0.05 nl/mm/min . In the absence of K in both bath
and perfusate, PD fell to —0.2 0.14 my, P <0.001, and Jv fell to
—0.13 + 0.07 nl/mm'/min1, P < 0.001. These effects were fully
reversible within ten minutes. Without K in the perfusate, there
was no change in PD or Jv. Absence of K in the bath led to
decreases in PD and Jv, comparable to those observed when K
was absent in both lumen and bath solutions. In further paired
studies, K was added to the bath in experimental periods in order
to reach concentrations of 0.5, 1.0, and 2.5 mEq/liter while the
lumen contained 5 mEq/liter. In comparison with control periods,
the following results were obtained: with 0.5 mEq/liter, PD was
17%, P < 0.005, and Jv was 24.4% of control, P < 0.001; with 1.0
mEq/liter: PD was 45%, P < 0.001, and Jv was 68.5%, P < 0.02;
with 2.5 mEq/liter: PD was 84.8%, P> 0.05, and Jv was 88.6%, P
> 0.05. In other studies, K concentration was raised to 10
mEq/liter in both perfusate and bath, and no significant effect on
PD or Jv was observed.
Hypertriglyceridemia (HTG) after transplantation (TX): Mecha-
nism and treatment. D. C. Cattran, G. Steiner, S. S. A. Fenton,
D. R. Wilson. Dept. of Medicine, University of Toronto, Toronto.
The study was designed to determine by serial samples the course
of dialysis (D) hyperlipemia in 20 patients, followed sequentially
up to 18 months after Tx, and to examine the pathogenesis using
triglyceride turnover studies (TGT). Cholesterol (C) did not
change. TG change by 12 months was suggestive, P = 0.10.
Patients
Time
months
Prednisone
mg/day
abnormal
% TG + 1 SEM C 1 SFM
D — — 60 183±18 212±14
Tx 3 26.5 57 185 + 17 206 + 8
Tx 12 13.5 49 169 + 9 214 10
To directly determine the influence of steroids on lipid kinetics,
seven patients who were stable three to nine months after Tx had
TG and TOT done and were then switched to equidose alternate
day steroids (ADS) over 3/12. Graft function did not change
(creatinine, < 1.8 mg/dl; proteinuria, < 0.5 g/24 hr).
Prednisone
mg/day
TG
mg/iOOml±sEM
TGT
mg/kg/hr
DS 15 203±3 10.68
ADS 30/0 128+5 6.32
HTG persists after Tx and is not closely related to DS dose. C
remains unchanged. A change to ADS results in normalization of
both TG and TGT. The HTG, in association with high TGT,
suggests that increased hepatic synthesis is the primary pathogenic
mechanism. The abnormal metabolic effect of DS on TG in Tx is
rectified by equidose ADS without immunologic effect (rejection).
Patients of more than six months after Tx with high TG should be
switched to ADS to avoid possible accelerated atherosclerosis.
Final results of a multicenter controlled trial of nandrolone deca-
bate (Deca-Durabolin) (DD) in the treatment of anemia of dialysis
patients. B. Richardson, D. Cattran, A. Shimizu, S. Fenton, and D.
Oreopoulos. University of Toronto, Toronto, and McMaster Univer-
sity, Hamilton. This study examined the effect of DD, an anabolic
steroid, on the anemia of 37 stable chronic dialysis patients (D)
known to be neither iron (I) nor B12 nor folate deficient. Male
dialysis patients, stable for 6 out of 12 months were randomized
into those who received DD, 200 mg i.m. weekly for 6 out of 12
months, or no treatment (C) with the crossover at 6/12. All re-
ceived an average of 200 mg of parenteral iron monthly plus oral
folate. Iron stores were assessed as adequate by bone marrow prior
to and at the end of the study. All serious illnesses or major blood
losses excluded D from analysis, so only 29 completed 12 months.
Anephric D (5 out of 29 patients) had no significant increase in
hemoglobin (Hgb) or hematocrit (Hct). Results in the remaining
24 patients were:
Pre-DD Treatment Post-DD
Time, months C1 C6 DD6 C6
Hgb, g/IOO ml
+ SEM 6.2 0.3 6.4 0.3 7.5 + 0.3 6.4 + 0.4
Hct,%±SEM 19+1 20+1 24±1 20±2
P value NS <0.005 <0.05
Seven patients had pain and/or hematoma at injection sites. No
hepatotoxicity was detected by liver function tests. Mean increase
in serum triglycerides from C1 —. DD6 was 60/100 ml. We conclude
that DD significantly improves the anemia of dialysis patients with
their kidneys in place but has no effect on anephric patients. The
high cost ($llOO/pt/yr) and the risks of treatment should limit DD
to patients with symptomatic anemia or frequent transfusion re-
quirements.
Investigation of the anti-brush border membrane antibody and its
antigenic determinants. S. Chant and M. Silverman. Univ. of To-
ronto, Toronto. Isoalted brush border membrane (BBM) fragments
from the renal proximal tubule of dog have been used to raise an
antiserum in rabbits. Indirect immunofluorescence shows that an-
tibody thus raised reacts only with BBM of proximal tubules of the
adult dog kidney. In adult dogs, the antibody also reacts with the
BBM of small intestine, gall bladder, luminal surface of epididymat
head tubular cells, luminal surface of pancreatic acinar cells, and
secretory cells of lacrimal gland. In the embryo and newborn dog,
the distribution is somewhat different: in the early embryo (18 days
p.c.) antigen can be demonstrated in all epithelia. At 21 days after
culture, it is present in the cytoplasm and surface membranes of
developing gut, stomach, liver, spleen, kidney, somites, and epi-
dermis. Forty-two-day embryos show staining of kidney proximal
tubule cells, BBM of the small intestine, liver cells, and cells
scattered throughout the spleen. In newborn dogs the kidney still
shows cytoplasmic as well as BBM staining of proximal tubule
cells. The small intestine shows BBM staining only, and stomach
epithelium does not stain. Liver shows staining of the bile canal-
iculi, and spleen shows cytoplasmic staining in islands of cells.
Antibody raised to adult dog BBM precipitates soluble maltase
released from BBM by papain digestion without affecting the
enzyme activity. Immunodifl'usion of antibody with papain di-
gested material shows one precipitin line. Certain BBM antigens of
the renal proximal tubule thus appear to be widely distributed
among absorptive and secretory epithelial surfaces and may pro-
vide useful markers for studies of these plasma membranes.
Predictability of serum gentamicin concentration (SGC) in renal
failure. D. Churchill, A. McNamara, I. Bowmer, M. Ahmed, and
M. H. Gault. Memorial University of Newfoundland, St. John's,
Newfoundland. SGC's were determined by radioimmunoassay (125I
gentamicin) in 16 patients at 20 dose levels one hour before and
one hour after gentamicin (G) dosage. Gentamicin was given i.m. 8-
hourly, after a loading dose of 1.7 mg/kg. Two others had only
trough SGC's determined. The creatinine clearance (Ccr) ranged
from 6 to 65 mI/mm (mean, 24 mI/mm). Ten patients with stable
renal function received a dose within 25% of that. The ranges of
mean trough and peak SGC's were 0.9 to 5.3 and 4.5 to 7.4g/ml
in nine patients. No value exceeded l2tg/ml. The correlation
coefficient between peak and trough SGC's was r = +0.84 (P <
005). CCr correlated only with trough values, r = —0.70 (P <
0.025). Considering all SGC's in the 16 patients, there was a linear
relationship between the ratio of actual dose to that calculated
from the nomogram and mean SGC values for both peak (y = 0.05
X + 1.7, r = +0.70, N = 20, P < 0.005) and trough values (y =
0.03 x +0.2, p = +0.67, N = 22, P < 0.005). The mean duration
of G therapy was nine days. Although SGC can be predicted
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satisfactorily in patients with stable renal function, repeated mea-
surement of SGC is necessary in those with changing renal func-
tion. Trough values predictably correlate with peak values and are
easier to obtain at the appropriate time in a clinical setting in
patients with renal failure.
Relationship between water hardness and the high incidence of
urolithiasis in Newfoundland. D. N. Churchill, G. Fodor, M. H.
Gault. Memorial University, St. John's, Newfoundland. There were
24.1 hospital separations for urolithiasis per 10,000 population per
year in Newfoundland (Statistics Canada 1972), 11.5 in Canada,
and 9.47 in the United States. The incidence in Newfoundland
exceeds that in any other province or state. The urolithiasis separa-
tions per 1,000 hospital separations and the mean water hardness
(ppm as calcium carbonate) values were obtained for 46 states. The
incidence of urolithiasis was significantly higher in states with a
mean water hardness <40 ppm (X2 = 7.879, P < 0.005). The mean
water hardness in Newfoundland is 16 ppm; the incidence of
urolithiasis is 16.6/1,000 hospital separations. Mean values in the
United States are 97 ppm (range, 17 to 299) and 7.4/100 (range, 2.3
to 15.0/1000). Urolithiasis separations/10,000 population/year
(197 1—74) were determined in each of the 39 Newfoundland statis-
tical districts. Five districts had an incidence <15/10,000 and 9 had
>30/10,000. Two of the five low incidence districts were on the
west coast and had relatively hard water (104 ppm). Seven of the
nine high incidence districts were along the north east coast; two
were on a south coast peninsula. The water hardness in these
districts was <20 ppm. The Avalon Peninsula has a water hardness
<10 ppm but had an intermediate incidence of urolithiasis. There
is an increased incidence of urolithiasis in areas with soft (<40
ppm) drinking water. Local genetic and dietary factors may play
an additive role in the extremely high incidence in some soft water
districts.
Significance of positive immunologic reactions to donor cells prior
to transplantation: Changing aspects. J. B. Dosseter, T. Kovitha-
vongs, K. B. Bettcher, J. Schlaut, and F. Pazderka. Department of
Medicine and Laboratory Medicine, University of Alberta, Canada.
The spectrum of tests against donor (D) cells designed to give the
best forecast of early renal allograft function now includes: com-
plement dependent cytotoxicity (CDC) to donor peripheral blood
lymphocytes (PBL) or B cells (B) by 51chromium release or dye
exclusion assay; complement independent agglutinations (CIAg)
against donor leukocytes, using the capillary or slide techniques;
antibody dependent cell mediated cytotoxicity (ADCC); lym-
phocyte mediated cytotoxicity (LMC) of donor cells by recipient
lymphocytes in short term (4 to 6 hr) and long term (16 to 20 hr)
incubation; and release by recipient cells of migration inhibitory
factor (MIF) on contact with donor cells, CDC.PBL by dye ex-
clusion is well accepted a a cause of hyperacute rejection; but
when 51Cr is used, positive reactions in CDC.PBL may like
CDC.B, be due to platelet non-absorbable antibody (against Ia-
like, not HLA-ABC antigens), and may be associated with good
early function. Positive CIAg (capillary) tests against donor PBL
are also associated with good graft function. Positive
ADCC.PBL(D) tests are associated with early rejection or very
good function, and the resolution of this confusion may depend on
whether or not the ab is platelet absorbable. When LMC.PBL(D)
is positive, early rejection is probable. With more data this obser-
vation implies cell-mediated crossmatching may be essential, as in
both our patients CDC.PBL was negative, by dye exclusion tech-
nique. In four positive MIF crossmatches, good early allograft
function has occurred.
Ribonuclease (RNAase) activity in patients with renal disease. M.
Gillen, E. Z. Rabin, V. Weinberger, B. Tattrie, and L. Chamberlain.
Division of Nephrology, Ottawa Civic Hospital, University of Ot-
tawa, Ottawa, Ontario. Plasma RNAase was measured using Poly
C as substrate (Rabin & Weinberger). Normal levels were 1047
247 U/mI. Plasma levels increase in all patients with renal failure;
there is a direct linear relationship between plasma RNAase and
serum creatinine. Hemodialysis patients have plasma levels that
very from 8,000 to 35,000 U/ml (mean, 17,900). Dialysis has no
effect on the RNAase concentration. Because human urinary ri-
bonuclease (mol wt, 33,000; and P1, 3.7) has been found to be
"toxic" in cultures of lymphocytes, bone marrow cells, and fat
cells, a systemic investigation of RNAase excretion was carried
out. Mean urinary excretions were: 3.45, 5.42, and 10.0 million
units per day in normals, in patients with primary glomerular, and
in patients with primary tubular diseases, respectively. Patients
with polycystic disease undergoing hemodialysis had mean plasma
levels of 23,900 U/mI but excreted 22.7 million units daily. The
ratio of
RNAase clearance
Xl00%
creatinine clearance
for the same group of patients was: 0.6 to 3.32% (normal); 3.4%
(primary glomerular); 9.6% (primary tubular); 23% (polycystic
kidney-hemodialysis). The simultaneous measurements of
RNAase and creatinine clearance provide information with regard
to the presence of significant tubular disease. Furthermore, the
data indicate that the increased plasma levels in uremia are due to
failure of the kidney to metabolize the enzyme as well as failure of
glomerular filtration.
Immune-complex glomerulonephritis secondary to celiac sprue. M.
Ho, R. Dyck, A. Katz, and R. A. Bear. University of Toronto,
Toronto, Canada. A 28-yr-old female was evaluated for a one year
history of diarrhea, polyarthralgias and polyarthritis, cutaneous
vasculitis, proteinuria, and gross and microscopic hematuria. Se-
rum creatinine was 0.8 mg/lOO ml; 24-hr urine protein excretion
was 1.12g. Additional laboratory data was: erythrocyte sedimenta-
tion rate, 98; rheumatoid factor, positive 1:1280; C3 complement,
72 mg/l00 ml (100 to 174); C4 complement, 6 mg/l00 ml (12 to
71); cryoglobulins, positive, and LE preparation; ANF and anti-
DNA-antibody, negative. Small bowel biopsy showed changes of
celiac sprue; skin biopsy revealed cutaneous vasculitis; and renal
biopsy demonstrated generalized proliferative glomerulonephritis
with extensive 1gM, IgA and B1C deposition. A gluten-free diet
was instituted. Arthralgias, arthritis, and cutaneous vasculitis dis-
appeared within one month. By four months, rheumatoid factor
and cryoglobulins were negative, ESR was 14, C3 and C4 com-
plement values were normal, urine sediment was normal, and 24
hour urine protein excretion was less than 50 mg. Circulating anti-
intestinal and anti-dietary antibodies have been described in
patients with celiac sprue. It has been suggested that extra-in-
testinal features of this disorder may be caused by circulating
immune complexes. The present case may represent an example of
immune-complex glomerulonephritis secondary to celiac sprue.
Renal osteodystrophy (RO): Effect of combined sequential ther-
apy with aluminum hydroxide (AH), high calcium bath (HCD), and
vitamin D2 (D). M. Johnson, M. Goldstein, C. Tam, and I. M.
Murray. Departments of Medicine and Pathology, St. Michael's
Hospital, and University of Toronto, Toronto. To evaluate the effec-
tiveness of AH, HCD, and D in the treatment of RU, nine patients
with chronic renal failure were studied in three sequential thera-
peutic modes after the initiation of chronic hemodialysis: stage I,
AH; stage 2, AH plus HCD (dialysate calcium (C), 5 mEq/liter);
stage 3, AH plus HCD plus D (50,000 to 100,000 U daily). The
findings were as follows:
AH AH+HCD AH+AHC+D
Normal serum Ca 3/9 5/8 8/8
Normal PTH 1/9 2/8 7/8
Alk. phosphatase 5/9 6/8 8/8
Quantitative bone morphometry demonstrated improvement in
osteitis fibrosa (OF) with HCD; however osteomalacia (UM) im-
proved only with addition of D. The results indicate 1) therapy
with AH alone was relatively ineffective in controlling RU, 2) PTH
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was easily suppressed as serum Ca rose with HCD, 3) bone biopsy
was essential for the diagnosis of OM, 4) no patient developed
clinically evident RO. This combined regimen with AH, HCD and
D was highly effective therapy in controlling RO.
Role of steroids in membranous glomerulonephritis. S. Karani-
colas, G. F. Kipkie, and P. A. F. Morrin. Queen's University,
Kingston. Membranous glomerulonephritis was diagnosed by renal
biopsy in 23 patients during an eight-year period. Twenty patients
had a 24-hr urine protein excretion greater than three grams, and
19 of these were treated with long-term alternate day Prednisone
therapy. Twelve of the 19 had a complete remission of proteinuria
and five others a pa'rtial remission while taking steroids. Only one
patient developed progressive renal failure, and in the remainder,
the disease did not appear to be progressive. It is concluded that
the current negative attitude to steroid therapy in this condition
should be reevaluated.
Epidemic of aseptic peritonitis caused by endotoxin during chronic
peritoneal dialysis. S. Karanicolas, D. G Oreopoulos, S. Izatt, A.
Shimizu. R. F. Manning, H. Sepp, G. A. de Veber, and T. Darby. The
Toronto Western Hospital, Toronto, St. Joseph's Hospital, Ham-
ilton, Ontario, Canada, and Baxter Laboratories, Morton Grove,
Illinois, U.S.A. The cause of aseptic peritonitis in patients under-
going chronic peritoneal dialysis is not known. During a four-week
period, 48 episodes of aseptic peritonitis occurred among 28
patients maintained on chronic peritoneal dialysis in two hospitals.
The permanent Tenckhoff catheter was used in 24 and the Deane's
prosthesis in 4 patients. Dialysate in two-liter plastic containers
was used in all. Diffuse abdominal pain with rebound tenderness
was the predominant finding and occurred on an average of seven
hours after initiation of dialysis. Removal of dialysate and discon-
tinuation of dialysis usually relieved the pain. Increased temper-
ature up to 38.6°C was present in 11 cases only. None of the
patients had rigors. The effluent fluid contained many white blood
cells (WBC) in all cases. On 28 occasions the fluid was cloudy.
Repeated cultures of effluent and blood were negative. Epidemio-
logic studies incriminated certain batches of dialysate in which
endotoxin was detected both by the limulus and rabbit pyrogen
tests. Further studies involving endotoxin injection into the pen-
toneal cavity of rabbits demonstrated that low concentrations of
endotoxins could produce elevated leucocyte counts in peritoneal
fluid. Our data suggest that endotoxin present in the dialysate can
cause aseptic peritonitis, and its presence should always be consid-
ered in all similar cases.
Monitoring of patients on chronic peritoneal dialysis by analysis of
ascitic fluid. J. Kelion, R. A. Ulan, R. Mitton, and C. R. Stiller.
Departments of Medicine and Nephrology, University Hospital, Uni-
versity of Western Ontario, London, Ontario, Canada. Ascitic fluid
composition in patients on chronic peritoneal dialysis (PD) could
provide a practical method of monitoring uremic abnormalities
without need for blood-sampling. The purpose of this study was to
compare the composition of ascitic fluid and blood in five patients
on chronic PD. Blood and ascitic fluid samples were obtained at
the start of fifty dialyses. Both samples were submitted for auto-
analyzer (SMA-13) analysis. The following correlation coefficients
were derived: phosphorus (0.99), uric acid (0.99), urea nitrogen
(0.98), creatinine (0.97), potassium (0.95), carbon dioxide (0.88),
chloride (0.84), calcium (0.83), sodium (0.83), albumin (0.63), total
protein (0.57), bilirubin (0.30), and glucose (0.27). The frequency
of obtaining three and five milliliter ascitic fluid samples was 71%
and 55%, respectively. It is concluded that ascitic fluid values for
phosphorus, uric acid, urea nitrogen, creatinine, and potassium
correlate well with blood levels. It is suggested that this method be
used in those PD patients in whom an adequate ascitic fluid sample
can be obtained.
Effect of methylprednisolone on in vitro parameters of the immune
response in the transplant recipient. P. Keown, C. R. Stiller, R. A.
Ulan, and D. McGirr. Department of Medicine, University Hospital,
University of Western Ontario, London, Ontario, Canada. Lym-
phocyte mediated cytotoxicity (LMC) can be induced both in vitro
and in vivo. It has been suggested that in vitro LMC is not suppres-
sible by steroids, although the generation ofcytotoxic effector cells
from an in vitro MLC is inhibited by these agents. Lymphocytes
from the recipients of renal allografts were studied in LMC assays,
using both 4- and 16-hr incubation with donor spleen cells. Cells
from normal controls were studied by in vitro induction of LMC.
The effect of dilutions of methylprednisolone (0 to 2,000 ig/ml) on
these assays was assessed by measurement of the percent of chro-
mium release from labelled target cells. It appears that killer cells
generated in viva and in Vitro may behave differently. In vivo
(rejection associated) LMC can be suppressed at levels of 20 ig/ml
if the cells are the previously described "primed or memory effec-
tor cells." This is to be compared to the four-hour LMC (rejection
associated). In vitro primed LMC can not be suppressed at this
concentration. There may be more than one subpopulation of
effector cells in the transplant recipient with varying sensitivity to
the major immunosuppressive agent used (MP), this having thera-
peutic implications. This system provides a working model for the
further investigation of the effectiveness of immunosuppressive
agents in the transplant recipient.
Urine protein electrophoretic studies in adult patients with poly-
cystic kidney disease and their families. T. Mycyk, G. A. Posen, and
E. Z. Rabin. Division of Nephro/ogy, Ottawa Civic Hospital, and
University of Ottawa, Ottawa. Sixty-five patients, including nine
families with a confirmed clinical and/or family history of poly-
cystic kidney disease (PKD), were studied in order to evaluate their
pattern of protein excretion. In addition to the routine clinical and
laboratory procedures, every patient's urinary protein pattern was
investigated by SDS-acrylamide gel electrophoresis. On the basis
of IVP's and/or nephrotomographs, PKD was diagnosed in 26
patients, every one of whom showed a pattern consistent with
tubular proteinunia. This abnormality was present even in the face
of normal renal function tests and normal rates of urinary protein
excretion. Of the 39 patients with normal IVP's and renal function
tests, 18 showed a tubular protein pattern, whereas no tubular
protein pattern was found in the remaining 21 cases. A prospective
study of the 18 patients showing only a tubular protein pattern is
underway to evaluate the nature of the underlying abnormality. As
no confirmed case of PKD has showed an absence of the tubular
protein pattern, it is suggested that this procedure be used as a
simple screening test for PKD.
Results of a prospective study on the effectiveness of three per-
manent peritoneal catheters. D. G. Oreopoulos, S. Izatt, G. Zeller-
man, S. Karanicolas, and R. F. Mathews. The Toronto Western
Hospital and A ccurate Surgical Instrument Company, Toronto, On-
tario, Canada. The effectiveness of the permanent Tenckhoff (T)
catheter was compared with that of the Goldberg (G) catheter,
which has a balloon on its intra-abdominal part, and a new cath-
eter devised in our Centre (TWH catheter) which, instead of the
balloon, has three flat silastic teflon disks attached. During a
nine-month period, 40 patients were systematically allocated to
each of the three catheters. Fifteen T, 18 G, and 15 TWH, all single
cuff catheters, have been implanted in these 40 patients. X-ray of
the catheter one month after implantation showed that 4/12 1,
3/15 G, and 1/13 TWH catheters were outside the pelvis. Per-
manent catheter obstruction occurred in 4 T, 2 G, and none of the
TWH catheters. Leakage of dialysate around the catheter was a
frequent complication of the G catheter. Transient rectal pain or
constipation, for periods of up to 2 months, was frequently en-
countered in patients with the TWH catheter. Catheter replace-
ment because of different complications was necessitated in 4 T
catheters, 4 G catheters, and I TWH catheter. The latter had to be
replaced while it was still functioning, because of a nonhealing skin
abscess. Our findings suggest that the TWH catheter is more effec-
tive than the Tenckhoff and Goldberg catheters.
Immunologic monitoring after transplant. T. Kovithavongs, J.
Sch/aut, F. Pazderka, K. B. Bettcher, and J. B. Dossetor. MRC
Transplantation Group and Departments of Medicine and Labora-
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tory Medicine, University of Alberta, Edmonton, Alberta. Serial
studies using recipient serum or lymphocyte against donor cells
stored in liquid nitrogen were carried out in the following test
systems: complement dependent cytotoxicity (CDC) by dye ex-
clusion (de) or chromium release (6tCr); complement independent
agglutinations (CIAg) by slide and capillary; antibody dependent
cellular cytotoxicity (ADCC) and lymphocyte-mediated cy-
totoxicity (LMC) against 51Cr-PHA transformed donor cells; and
release of migration inhibitory factor (MIF). Difficulties encoun-
tered included poor donor cells, making it impossible to carry out
the tests in several recipients and inability to obtain sufficient
numbers of recipient cells on occasions for testing in cell mediated
systems. LMC, the single most useful test in others' hands had not
met with equal success for several reasons: poor donor cells or
insufficient numbers of recipient cells mentioned above, high back-
ground of 51Cr release due to spontaneous LMC in normals when
used as controls and nonspecific recipient lymphocyte activation
by virus, etc. Despite all these, LMC, when positive, remains
highly predictive of rejection crisis and was associated with rejec-
tion on one or more occasions in seven of eight patients. MIF
developed after transplant was associated with rejection in four in
whom LMC was not helpful. De-CDC-PBL is predictive of rejec-
tion but de-CDC-B is not. 51Cr-CDC and ADCC may or may not
accompany rejection; platelet absorption may further resolve this
issue. Finally, certain transplant rejects developed widespread im-
munity against panel, a finding potentially useful in predicting
graft rejection when donor cells are not available.
Results from eleven years treatment of terminal renal failure at the
Vancouver General Hospital. J. D. E. Price, K. McDowell, and C. E.
Reeve, University of British Columbia, Vancouver, B. C. In the 11
years commencing Nov. 2, 1964, 265 patients (pts) have been
treated for a total of 9,880 patient months. All patients with
terminal renal failure presenting to the Unit were dialyzed unless
they had metastatic cancer or a similar medical contraindication.
Cases were referred from as far away as 850 miles. Ages ranged
from 13 months to 66 years with a mean of 37 years, 3 months.
Results have been analyzed by the life table method. Combining all
methods of therapy the half-life (50% surviving) for patient sur-
vival is 5 years, 10 months. For patients aged 20 to 50 years, the
half-life was 7 years, 3 months; aged over 50 years, was 2 years 6
months; and for age 0 to 19 years, survival was 72% at 6 years.
Center hemodialysis and cadaver transplant (1st kidney) had the
highest survival rates, the survival being similar in both groups.
Home dialysis was next with a half-life of 5 years, and peritoneal
dialysis was lowest partly due to patient selection. Analysis by
renal diagnosis showed little difference in overall survival between
patients with chronic glomerulonephritis, chronic pyelonephritis,
and polycystic disease. Analgesic nephropathy had a poorer prog-
nosis, and hypertensive renal disease had the worst prognosis.
There were 90 deaths including cardiovascular, 23 (25%); infection,
16 (18%); suicide, 5(6%). In our experience home dialysis without
proper follow-up support is only viable for a limited time. In the
age group below 50, renal transplant and center hemodialysis have
equal survival, suggesting that transplant is the treatment of
choice.
Idiopathic calcium nephrolithiasis: Role of urine saturation with
brushite and urine inhibitors of calcification. G. Pylypchuk, U. Ehrig,
S. Fox, D. R. Wilson. Department of Medicine, University of To-
ronto. Urine saturation with brushite (CaHPO4.2H20), in vitro
collagen calcification by urine, urine inhibitors of collagen calcifi-
cation, and urine crystalloids (calcium, magnesium. phosphorus,
uric acid, citrate, oxalate) were compared in 64 patients with
recurrent calcium stone formation (SF) and 30 normal subjects
(N). Mean urine saturation with brushite was higher in SF than N,
(activity product ratio, 1.68 0.08 vs. 1.23 + 0.08, P < 0.01).
Collagen calcification by urine in vitro was also higher in SF (P <
0.01). Urine saturation with brushite correlated with the percent of
collagen calcification by urine and with urine calcium concentra-
tion in both groups. Urine inhibitors, both total and concentra-
tion, were higher in SF than in N (P < 0.01). Mean 24-hr calcium
excretion was higher in SF, and the magnesium to calcium ratio
was lower, P < 0.01. Uric acid and oxalate were not different, but
citrate was lower in SF, 494 23 mg/24 hr vs. 669 + 44, P < 0.01.
We conclude that 1) urine of SF has a greater propensity than that
of N to precipitate as brushite, either spontaneously because of
supersaturation or on a nidus (collagen), 2) inhibitors of collagen
calcification (calcium phosphate precipitation) do not play a signif-
icant role in stone pathogenesis, 3) low urine magnesium to cal-
cium ratio and urine citrate may be important in SF.
Glomerulonephritis with epithelial crescents: A clinico-pathologic
review. E. K. M. Smith, S. Kumar, and J. Minielly. Hamilton
Regional Nephrology Programme, St. Joseph's Hospital, Hamilton,
Ontario. Renal biopsies obtained from 521 patients over a six-year
period have been reviewed to determine the incidence and signifi-
cance of glomerular epithelial crescents. They were seen in 29 cases
(5.5%) which fell into two diagnostic groups: 1) Primary renal
disease (16 cases) which included a) poststreptococcal glomerulo-
nephritis (4), b) idiopathic glomerulonephritis (8), c) Goodpas-
ture's syndrome (4); 2) Secondary renal disease (13 cases) which
included a) anaphylactoid purpura (7), b) systemic lupus erythema-
tosus (4), c) systemic vasculitis (2). Twenty cases with less than 50%
of glomeruli involved by crescents included all those with post-
streptococcal glomerulonephritis and all those with secondary
renal disease, while all nine cases with more than 50% crescents had
primary renal disease. Prognosis was closely related to the propor-
tion of glomeruli with crescents: all nine patients with more than
50% crescents had advanced renal failure one year after biopsy,
eight had entered the kidney replacement programme, and one had
a plasma creatinine of 7.2 mg/lOO ml. Among those with less than
50% crescents, however, 90% improved or stabilized. There was no
evidence that any particular therapy benefited patients with
primary renal disease, and the clinical outcome depended more
upon the proportion of crescents than any other feature. Details of
clinical and pathological findings will be presented together with a
rational approach to the management of crescenteric glomerulo-
nephritis.
Specific pre-transplant sensitization to donor antigens. C. R. Stil-
ler, N. R. Sinclair, W. Howson, D. McGirr, S. Abrahams, andR. A.
Ulan. University Hospital, London, Canada. Cadaver graft recipi-
ents were cross-matched against donor lymphocytes using lym-
phocyte-mediated cytotoxicity (LMC) and antibody-dependent
cell-mediated cytotoxicity (ADCC) techniques. Results of these
assays were disregarded in making the decision to transplant and
the clinical results analyzed. Thirty-nine recipients were tested for
ADCC and 36 for LMC before transplantation. All donor-recipi-
ent pairs were complement-dependent cytotoxicity (CDC) nega-
tive. Thirty-nine consecutive cadaver graft recipients, where donor
lymphocytes were available, either from the spleen (SL) or donor
peripheral blood lymphocytes (PBL), were cross-matched with
recipient blood taken on the day before transplant. LMC was
performed against phytohemogglutinin (PHA)-treated (24 to 48
hr) 51chromium-PBL or SL. The incubation time was 16 hr. ADCC
was performed using PHA-treated PLB or SL, 51Cr labelled, with a
four-hour incubation time. Those results were confirmed using
non-PHA-treated lymphocytes. All tests were done in triplicate,
and a significant difference (P < .05) between the serum or cell
(third party unrelated) control and the experimental group was
obtained. The results were expressed as specific chromium release.
CDC was performed using the Terasaki dye exclusion assay (one-
hour incubation). The results of these crossmatch studies were
compared in relation to whether clinical rejection occurred in the
first 48 hr after transplantation (accelerated rejection) and whether
the kidney had been rejected by one month.
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Accelerated Rejection Rejected one month
+ — P + — P
LMC + 4 0
— 0 32 0.001
3 l
7 25 0.05
ADCC + 4
— 0 32
0.001
7 25
0.07
LMC
ADCC
+ 1 0
— 0 32
0.03
0 1
7 25
0.79
Creatinine = 5.9.
A positive crossmatch by the LMC and ADCC assays predicted an
accelerated rejection indicating pretranspi ant sensitization, and a
marginally poorer one month survival.
Morphologic evidence of perfusion injury in machine-preserved
kidneys. R. A. U/an, A. C. Wallace, J. F. B. Lockwood, P. Keown,
C. R. Stiller. Departments of Medicine and Pathology, University
Hospital, University of Western Ontario, London, Ontario, Canada.
Machine perfusion preservation of cadaveric kidneys has been
reported to result in a spectrum of glomerular endothelial changes,
platelet and fibrin deposition, and a higher failure rate than kid-
neys preserved by hypothermia alone. In the past four years, 20
cadaveric kidneys were harvested and placed on perfusion preser-
vation but not transplanted because of vascular problems or lack
of a suitable recipient. Preservation was with a Gambro system
using an albumin perfusate. The distribution of the kidneys ac-
cording to the perfusion time was: 0 to 2 hr (3), 2 to 24 hr (4), 24 to
48 hr (7), 48 hr (6). A wedge of each kidney was submitted for
light, immunofluorescent, and electron microscopic study. Immu-
noflourescent findings were not remarkable. Glomerular changes
(endothelial lesions, basement membrane change, foot process fu-
sion) and tubular changes (dilatation, vacuolation, multinucleated
cells, mitrochondrial swelling, cell lysis) were quantitated on a 0 to
++++ scale. Only the endothelial lesions (varying from slight cell
separation to total denudation) and basement membrane altera-
tions (varying from small foci of fraying to total dissolution)
correlation with perfusion time. The six kidneys perfused for
longer than 48 hr had the severest changes. These findings support
the concept that perfusion preservation causes endothelial and
basement membrane injury which may be detrimental to graft
function.
Tubular ectasia: A common cause of calcium stones? E. R. Yendt,
S. Jarzylo, and M. Cohanim. Departments of Medicine and Radiol-
ogy, Queen's University, Kingston, Ontario. Eight hundred relatively
unselected patients with renal calculi have been investigated by us
in Kingston between 1968—76. The incidence of medullary sponge
kidneys in the first 300 patients was 5%. In the last 100 patients,
evidence of tubular ectasia has been detected in 25% as a result of a
much more careful scrutiny of iv. pyelograms. Moreover, in a
review of iv. pyelograms of patients previously diagnosed as hav-
ing idiopathic hypercalciuria or idiopathic calcium stones, tubular
ectasia has been found in almost 50% of 33 patients examined to
date. Although the relationship of the observed changes to the
pathogenesis of renal stones remains to be proven, we will present
preliminary evidence that these changes are frequently accom-
panied by functional disturbances of the nephron. Many of the
patients are hyprcalciuric, and the serum ultrafiltrable calcium in
51 male hypercalciuric patients with tubular ectasia is slightly but
significantly lower than in 49 male patients with idiopathic hyper-
calciuria. Serum PTH levels have been elevated in 3 of 14 normo-
calcemic patients with tubular ectasia. One patient, believed to be a
case of tertiary hyperparathyroidism resulting from medullary
sponge kidney, will be presented. In addition to reviewing the
radiographic and biochemical features of these patients, we will
also describe a rather characteristic clinical syndrome which has
been observed in a small group of them. The results of a blind
analysis of the incidence of tubular ectasia in routine iv. pyelo-
grams, which has just been initiated, will also be presented.
Trial of ibuprofen therapy in young children with Bartter's syn-
drome. E. D. Wolff, J. W. Balfe, and G. S. A rbus. Univ. of Toronto,
Hosp. for Sick Children, Toronto, Canada. Bartter's syndrome (BS)
is a rare form of renal sodium wasting associated with hypoka-
lemia, metabolic alkalosis, and hyperreninemia with a normal
blood pressure. Recently it has been proposed that prostaglandin
excess may play a role in this syndrome and that prostaglandin
synthesis inhibitors, such as inbuprofen (lB), can cause improve-
ment. We studied the effect of giving 20 to 30mg/kg of body wt per
day of lB to two patients with BS: a six-year-old female (patient
no. 1) and a three-year-old male (patient no. 2). Spironolactone
was discontinued three days prior to the study. They remained on
sodium chloride and potassium chloride supplements. For three
days prior to starting lB and for the nine-day period of drug
administration, metabolic balances were done. There were appre-
ciable differences between the control (mean of three days) and
experimental period (mean of last four days on lB therapy) with
certain parameters:
B
Pat. I
ody wt,
kg
Pat. 2
Blood
vol.
ml/kg
Plasma
vol.
mi/kg
Plasma
K.F
mEq/liter
Pat. I Pat. 2
Uom
mOsm/liter
Pat. I Pat. 2 Pat. I Pat. 2 Pat. I Pat. I
Control 13.2 10.2 65 71 46 46 2.1 1.9 368 364
lB 13.7 10.8 76 82 55 53 2.5 2.6 336
Subjective improvement in affect and motor ability were noted in both children while on TB. There were no changes from control in bromide
space, plasma bicarbonate, and sodium levels, and RBC sodium and potassium levels. In two children with BS, specific fluid and electrolyte
parameters were modified while on short-term lB therapy. The consequences of long-term lB medication in such children remain to be
determined.
